Sageone Inhibitor

Name: Sageone Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5763059
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5763059

Sageone represents a promising anticancer agent against gastric cancer that warrants further study, it synergizes with cisplatin cytotoxicity in SNU-1 human gastric cancer cells.Sageone also shows antiviral activity. More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Sageone, Inhibitor

Full Product Name

Sageone

Form/Format

Solid. Powder

Purity/Purification

98.00%

Preparation and Storage

Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent

Molecular Weight

298.4

Solubility

<1mg/ml refers to the product slightly soluble or insoluble

Formula

C19H22O3

CAS Number

142546-15-4

Target & IC50

Akt
Antifection
Caspase
PARP

Product Categories/Family for Sageone, inhibitor

Cytoskeletal Signaling; Akt; Apoptosis; Proteases/Proteasome; Chromatin/Epigenetic; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling; Microbiology&virology

Product References and Citations for Sageone, inhibitor

Sageone, a diterpene from Rosmarinus officinalis, synergizes with cisplatin cytotoxicity in SNU-1 human gastric cancer cells. Phytomedicine: international journal of phytotherapy and phytopharmacology, 2016, 23(13):1671-1679.

Other Notes

Small volumes of Sageone, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Sageone purchase

MBS5763059 is an inhibitor targeting Sageone.